Not Yet Recruiting
A Phase II Study of AK104 Combination With Lenvatinib Versus Lenvatinib for Second-line HCC
NCT06984718
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
Not specified